Discover 179 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 179
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 40 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: 17 recruiting locations
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Active & Responsive
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
for
Burns, Trauma
Location: 1 recruiting location
Sponsor: University of South Alabama
Sex: All
Age: 19 - 70
Code: NCT01812941
Recruiting
Active & Responsive
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
for
Female Contraception
Location: 41 recruiting locations
Sponsor: Mylan Pharmaceuticals Inc
Sex: Female
Age: 16+
Code: NCT06672016
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
for
Tricuspid Valve Disease
Location: 4 recruiting locations
Sponsor: CorMatrix Cardiovascular, Inc.
Sex: All
Age: 1 - 70+
Code: NCT02397668
Recruiting
Active & Responsive
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
for
Large B-cell Lymphoma
Location: 30 recruiting locations
Sponsor: Celgene
Sex: All
Age: 18 - 70+
Code: NCT06356129
Phase3, Recruiting
Active & Responsive
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)